COMMUNIQUÉS West-GlobeNewswire

Emerald Health Therapeutics’ Joint Venture Pure Sunfarms Begins Shipping Branded Cannabis Product to British Columbia Provincial Wholesaler
04/10/2019
VANCOUVER, British Columbia, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), today announced its 50%-owned joint venture for large-scale, low-cost, high-quality [...]
United Health Products Announces Submission of Premarket Approval (PMA) Application to the U.S. FDA for the HemoStyp® Device for Use in Surgical Procedures
04/10/2019
HENDERSON, Nev., Oct. 04, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC: UEEC) today announced that it has submitted a Premarket Approval (PMA) application for Class III approval to the FDA for [...]
Fulcrum Therapeutics Announced Results of Phase 1 Clinical Trial of Losmapimod in FSHD
04/10/2019
Data presented in an oral presentation at World Muscle Society meeting highlighted safety, tolerability, pharmacokinetics and target engagement of losmapimod in patients with facioscapulohumeral dystrophy. CAMBRIDGE, [...]
Chi-Med Initiates an International Phase I/Ib Trial of HMPL-523 in Patients with Advanced Relapsed or Refractory Lymphoma
04/10/2019
LONDON, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“ Chi-Med ”) (AIM/Nasdaq: HCM) has initiated an international Phase I/Ib study of HMPL-523, its novel spleen tyrosine kinase (“Syk”) inhibitor [...]
Statement re: Appointment of Corporate Broker
04/10/2019
DXS INTERNATIONAL PLC Appointment of Corporate Broker The Board of DXS International plc (“the Company”), the NEX Growth Market quoted healthcare information and digital clinical decision support systems provider, is [...]
Press news Biocartis Group NV: Disclosure of a transparency notification
04/10/2019
PRESS RELEASE : REGULATED INFORMATION 4 October 2019, 7:00 CEST Disclosure of a transparency notification Mechelen, Belgium, 4 October 2019 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular [...]
NOTICE TO DISREGARD – Dabir Surfaces
04/10/2019
CHICAGO, Oct. 03, 2019 (GLOBE NEWSWIRE) -- We are advised by Dabir Surfaces that journalists and other readers should disregard the news release, “Dabir Surfaces Inc. Announces Master Product Agreement with Trinity [...]
Noushin Khoiny
04/10/2019
Dr. Noushin Khoiny discusses new California laws and how they will impact primary health care provider prescribing practices Long Beach, California, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Dr. Noushin Khoiny gave a talk on [...]
Novelion Therapeutics Announces Filing of Definitive Proxy Statement in Connection with Proposed Liquidation and Other Matters
04/10/2019
VANCOUVER, British Columbia, and CAMBRIDGE, Mass., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”) today announced that it has filed its notice of meeting and [...]
WW Announces Prepayment of Portion of Term Loan Facility
03/10/2019
NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- On October 3, 2019, WW International, Inc. (NASDAQ: WW) announced that it intends to voluntarily prepay $50 million in aggregate principal amount of term loans outstanding [...]
Arbutus Announces Decision to Discontinue Development of AB-506, an Oral Capsid Inhibitor for the Treatment of Chronic Hepatitis B
03/10/2019
WARMINSTER, Pa., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a Hepatitis B Virus (HBV) therapeutic solutions company, today announced its decision to discontinue the clinical [...]
Aptevo Therapeutics Provides Corporate and Pipeline Update
03/10/2019
Reports Record Quarterly IXINITY ® Net Revenue and New Patient Conversions Following Launch of New 3,000 IU Assay Provides Update on Ongoing APVO436 Phase 1/1b Clinical Study; Evidence of Potential Clinical Activity [...]
Entasis Therapeutics Announces Multiple Presentations at ID Week 2019
03/10/2019
CEO Dr. Manos Perros participated in Industry Panel today WALTHAM, Mass., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company developing novel [...]
Ovid Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock
03/10/2019
NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of patients with rare neurological diseases, [...]
Molecular You Introduces New Precision Fitness Playbook: myFitnessFx™
03/10/2019
Takes the guesswork out of fitness programs with precision fitness metrics VANCOUVER, British Columbia, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Molecular You , the personalized health company, today announced the launch of [...]
Parexel and HealthVerity Announce Strategic Partnership to Address Complex Clinical Research Questions with Customized Real-World Data Solutions
03/10/2019
Parexel customers now have access to data for more than 330 million patients that can be linked from more than 60 anonymized healthcare and consumer data sources BOSTON and PHILADELPHIA, Oct. 03, 2019 (GLOBE NEWSWIRE [...]
Number of voting rights as of September 30. 2019
03/10/2019
Nicox SA Société anonyme with a registered capital of € 29,914,920 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On October 3, 2019, MONTHLY PUBLICATION OF THE [...]
Nombre de droits de vote au 30 septembre 2019
03/10/2019
Nicox SA Société anonyme au capital de 29 914 920 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 3 octobre 2019, PUBLICATION MENSUELLE DU NOMBRE D’ [...]
Spineway : Report on the October 3, 2019 General Shareholders’ Meeting
03/10/2019
Report on the October 3, 2019 General Shareholders’ Meeting The Spineway Ordinary and Extraordinary Shareholders' Meeting met, on second notice after adjournment, on October 3, 2019 at 11:00 am at the company's [...]

Pages